- FOUNDED 2007
Overview
The Cancer Genetics Group provides a national forum for discussion and interaction among clinical, research and support service personnel engaged in cancer genetics research, treatment and management.
Originally established as the Familial Cancer Group within COSA, the Group merged with the Human Genetics Society of Australasia (HGSA) Cancer Genetics Special Interest Group in 2020.
The Group is represented by an Executive Committee with interest in the germline and somatic aspects of cancer genetics.
Membership includes a broad range of professionals, including: Clinical Geneticists, Genetic Counsellors, Oncologists, Scientists, Researchers and others who have an interest in cancer genetics across Australasia.
Some of the issues in which the Group has interest include:
- supporting continuing education of cancer health care professionals on relevant cancer genetics topics
- facilitating networks within familial and/or somatic cancer genetics communities in Australia to accelerate the translation of genetic discoveries into meaningful improvements in care pathways and outcomes for patients
- development of consistent clinical protocols across Australia
- advocacy on issues related to cancer genetics
The Group holds professional development days and webinars, and contributes to various scientific meetings.
Group information
COSA and HGSA Cancer Genetics Group Terms of Reference – Council approved 16 October 2020
What’s the latest
Group Chair
Group Chair
Simon Troth
Cancer Genetics Group Chair
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 15 hours ago
Congratulations David Thomas for recognition of your leadership and groundbreaking work in genomics in cancer care. And congratulations to all the recipients of the 2024 Premier's Awards for Outstanding Cancer Research.#cancerNSWawards https://t.co/7oNiXcKA3n
Read More >
COSAoncology 15 hours ago
Congratulations Ashfaq Chauhan for recognition of your work to enhance cancer care for people from CALD backgrounds. https://t.co/HUi1nsuuzX
Read More >
COSAoncology 16 hours ago
Congratulations @DrNicolasHart for recognition of your work to improve outcomes of all people affected by cancer. https://t.co/7QQoSk0bvf
Read More >
COSAoncology 16 hours ago
Congratulations @yapml for recognition of your important work in equity and cancer care. https://t.co/Wli1hzRDxv
Read More >
COSAoncology 6 days ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 in Melbourne, 6-7 March. We particularly welcome submissions from survivors themselves and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF pic.twitter.com/vjp4hfcVXN
Read More >
COSAoncology 7 days ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 to be held in Melbourne, March 2025. We particularly welcome submissions from survivors and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/87PUAMTxwA
Read More >
COSAoncology 10 days ago
It's a wrap! Thanks to everyone who made #COSA24 a huge success, not least the almost 900 delegates who joined us on the Gold Coast. Watch the video for all the stats. pic.twitter.com/ysZNul66qH
Read More >
COSAoncology 10 days ago
@sdent_cardioonc spent many years providing cancer care in Ontario Canada and was delighted to take home @garvey_gail's 'Indigenous and Tribal Peoples and Cancer' from #COSA24. @sdent_cardioonc shared her expertise on cardiovascular multimorbidity and cancer at the ASM. https://t.co/1Db1QSn3py
Read More >
COSAoncology 10 days ago
Job well done! #COSA24 Co-convenors Michael Powell and Sean Hill delivered an amazing meeting. Time to relax ... almost. See what's left on the program https://t.co/ACGrZGt2Ee pic.twitter.com/NVi9bY1fiL
Read More >
COSAoncology 10 days ago
You won't want to miss the #COSA24 plenary on AI in Healthcare with presenters @thedeanh @dhansen35 and Prof Catherine Jones. Followed by a panel discussion at Q&A. Today at 1:30pm pic.twitter.com/AEgtwaqSIS
Read More >